Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Japan.
Clin Exp Hypertens. 2009 Nov;31(8):625-38. doi: 10.3109/10641960903406993.
Diurnal variations in plasminogen activator inhibitor-1 mRNA expression are different between the spontaneously hypertensive rats (SHRs) and the Wistar-Kyoto (WKY) rats, and between the aorta and the heart. To elucidate the mechanisms, we examined diurnal changes in the circulating renin-angiotensin system in the SHR and WKY rats. Diurnal variations in plasma renin activity (PRA), plasma angiotensin I, and aldosterone concentrations were similar between the SHR and WKY rats. On the other hand, plasma angiotensin II (Ang II) concentration in the SHR was lower than that in the WKY rats at most time points, but increased to the level of the WKY rats in the late light phase. Treatment with AT1 receptor antagonist candesartan increased plasma Ang II concentration except at ZT 8 and lessened its diurnal variation in the SHR. At the peak in plasma Ang II in the SHR, Ang II regulated genes such as transforming growth factor-beta1 and p22phox were upregulated in the aorta. On the other hand, these genes were upregulated throughout the day in the heart of SHR. Candesartan treatment increased AT1a receptor mRNA expression in the heart but not in the aorta of SHR. These findings suggest that an AT1 receptor-mediated mechanism might cause a surge in plasma Ang II concentration at the late light phase in the SHR. Homologous down-regulation of AT1a receptor by Ang II may dampen the effect of a surge in plasma Ang II concentration in the heart of SHR.
血管紧张素原抑制剂-1mRNA 表达的昼夜变化在自发性高血压大鼠(SHR)和 Wistar-Kyoto(WKY)大鼠之间以及主动脉和心脏之间存在差异。为了阐明这些机制,我们检测了 SHR 和 WKY 大鼠循环肾素-血管紧张素系统的昼夜变化。SHR 和 WKY 大鼠的血浆肾素活性(PRA)、血管紧张素 I 和醛固酮浓度的昼夜变化相似。另一方面,SHR 中的血浆血管紧张素 II(Ang II)浓度在大多数时间点均低于 WKY 大鼠,但在傍晚光期增加到 WKY 大鼠的水平。用 AT1 受体拮抗剂坎地沙坦治疗可增加血浆 Ang II 浓度,但可减轻 SHR 中其昼夜变化。在 SHR 血浆 Ang II 达到峰值时,血管紧张素调节基因如转化生长因子-β1 和 p22phox 在主动脉中上调。另一方面,这些基因在 SHR 心脏中全天都上调。坎地沙坦治疗可增加 SHR 心脏而不是主动脉中的 AT1a 受体 mRNA 表达。这些发现表明,AT1 受体介导的机制可能导致 SHR 在傍晚光期血浆 Ang II 浓度激增。Ang II 对 AT1a 受体的同源下调可能会抑制 SHR 心脏中血浆 Ang II 浓度激增的作用。